Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Cell Line Development Companies

Cell line development companies play a crucial role in the biopharmaceutical industry by providing cell lines for the production of biopharmaceuticals, vaccines, and other medical products. These companies offer a range of services to facilitate the development, selection, and optimization of cell lines for the production of various biologics.

*Disclaimer: List of key companies in no particular orderLatest Cell line development Companies Update

May 2023: To speed up innovation and growth for its international biopharma customers, JSR Life Sciences declared that KBI Biopharma, Inc. (KBI) and Selexis SA would merge into a single entity named KBI Biopharma. Integrated, seamless options for customers, from cell line creation through process development to clinical and commercial cGMP production services for mammalian programs, will be made possible by the new structure, claims JSR. The more flexible, efficient, and streamlined operational model helps customers accelerate medication development and manufacturing while streamlining the partner experience. KBI Biopharma and Selexis have combined their strengths and knowledge to lower manufacturing risks for clients. As a key component of the whole JSR, the united entity will use the aggregate knowledge, scientific skill, and technological prowess of KBI.

June 2023: Lonza disclosed that it had acquired Synaffix, a biotechnology firm based in the Netherlands with an antibody drug conjugate (ADC) technology foundation. According to the agreement, Lonza will make a cash upfront payment of €100 million and up to an extra €60 million in performance-based compensation. Even though Synaffix is now a part of Lonza, it will continue to operate under the Synaffix brand and expand its base of operations in Oss, the Netherlands, to be ready for future innovation and expansion. The payload and site-specific linker components of Synaffix's ADC technology platform will improve and expand Lonza's integrated ADC services, particularly Lonza's early-phase offering. The GlycoConnect, HydraSpace, and toxSYN methods, which are proprietary and potentially dramatically improve the efficacy and tolerance of ADCs, are part of the ADC technology platform.

List of Cell line development Key companies in the market

American Type Culture Collection (ATCC) (US)

Lonza Group AG (Switzerland)

Thermo Fisher Scientific Inc. (US)

GE Healthcare (US)

Sigma-Aldrich Corporation (US)

Selexis SA (Switzerland)

Promega Corporation (US)

Corning Inc. (US)

WuXiAppTec Inc. (China)

Sartorius AG (Germany)

Cell Line Development Market Highlights:

Cell Line Development Market Size

Cell Line Development Market Trends

Cell Line Development Market Analysis

Cell Line Development Market Share

Cell Line Development Market Highlights:

Cell Line Development Market Trends

Cell Line Development Market Analysis

Cell Line Development Market Share

Cell Line Development Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.